Audio poster

Estimation of the Impact on Treatment Costs of a Switch to Nonacog Beta Pegol (N9-GP) for the Treatment of Adults with Hemophilia B in Canada Based on Real-World Factor IX (FIX) Consumption and Clinical Outcomes Pre- and Post-Switch

Author
Vance MacDonald, Xin Ying Lee, Alexandre Caillaud, Maria Luckevich, Anthony Bentley
Citation
Vance MacDonald, Xin Ying Lee, Alexandre Caillaud, Maria Luckevich, Anthony Bentley; Estimation of the Impact on Treatment Costs of a Switch to Nonacog Beta Pegol (N9-GP) for the Treatment of Adults with Hemophilia B in Canada Based on Real-World Factor IX (FIX) Consumption and Clinical Outcomes Pre- and Post-Switch. Blood 2020; 136 (Supplement 1): 19. doi: https://doi.org/10.1182/blood-2020-134236
Date of Publication

This website is intended
for healthcare professionals (HCPs)
outside of the U.S.

Take me to www.novonordisk.com